Market Place
Sourcing Support
4baseCare expands global footprint, launches operations in Dubai
25 Oct 2024 //
BIOSPECTRUM
Illumina updates benchtop sequencer with push-button workflows
10 Oct 2024 //
FIERCE BIOTECH
Illumina`s pitch for new machines: You, too, can sequence DNA
09 Oct 2024 //
ENDPTS
Illumina wins Grail battle in blow to EU merger power
03 Sep 2024 //
REUTERS
FDA Approves Illumina`s Pan-Cancer Companion Diagnostic Test
28 Aug 2024 //
FIERCE BIOTECH
Cancer test maker Grail cuts 350 jobs as part of restructuring program
13 Aug 2024 //
REUTERS
Illumina Expects Core Segment Sales Decline Due To Biotech Crunch
07 Aug 2024 //
REUTERS
Grail’s cancer blood test makes ground in massive U.S., U.K. clinical studies
17 Jul 2024 //
FIERCE BIOTECH
Illumina Acquires Fluent BioSciences To Expand Single-Cell Analysis Capabilities
11 Jul 2024 //
PHARMABIZ
Illumina Acquires Fluent BioSciences For Single-Cell Analysis Expansion
10 Jul 2024 //
FIERCE BIOTECH
Illumina to take $1.47 bln goodwill impairment charge related to Grail in Q2
27 Jun 2024 //
REUTERS
Grail bets big on flagship cancer test after spin-off from Illumina
25 Jun 2024 //
REUTERS
Grail to become an Illumina spinout, once again, and go public
04 Jun 2024 //
FIERCE BIOTECH
Illumina Drives Genomic Testing In Oncology At ASCO Presentations
30 May 2024 //
PR NEWSWIRE
Integrated Bio: Illumina Venture For Novel Transcriptome Therapeutics
28 May 2024 //
BUSINESSWIRE
Illumina takes a step toward spinning off Grail, though keeps open for sale
06 May 2024 //
ENDPTS
EU approves Illumina`s plan to divest cancer test maker Grail
13 Apr 2024 //
REUTERS
Exclusive: Icahn drops Illumina board challenge threat, sources say
13 Mar 2024 //
REUTERS
Chinese rival to Illumina struggles with US expansion
14 Feb 2024 //
ENDPTS
Illumina forecasts flat 2024 sales as sluggish demand drags on
08 Feb 2024 //
REUTERS
Carl Icahn tries, again, to use secret info from Illumina board member
24 Jan 2024 //
REUTERS
Icahn ordered to remove lawsuit’s information that was supplied by Illumina
16 Jan 2024 //
ENDPTS
Illumina Ventures launches refreshed startup accelerator program
12 Jan 2024 //
FIERCE BIOTECH
Illumina reports stronger-than-expected growth
09 Jan 2024 //
ENDPTS
Delfi Diagnostics hires Illumina’s chief commercial officer as next CEO
04 Jan 2024 //
ENDPTS
Activist Icahn prepares a second board challenge at Illumina -letter
18 Dec 2023 //
REUTERS
Illumina to divest Grail, two years after $8B deal was stymied
18 Dec 2023 //
ENDPTS
US court strikes down FTC order against Illumina`s purchase of Grail
15 Dec 2023 //
REUTERS
Illumina CFO says there`s outside interest in Grail as `outright sale` explored
28 Nov 2023 //
ENDPTS
Illumina cuts annual profit forecast for second straight quarter
09 Nov 2023 //
REUTERS
Veracyte Announces In Vitro Diagnostic Agreement with Illumina
07 Nov 2023 //
BUSINESSWIRE
Carl Icahn sues Illumina board members over Grail acquisition
18 Oct 2023 //
ENDPTS
Illumina receives EU order to divest Grail
12 Oct 2023 //
ENDPTS
Myriad Genetics and Illumina Achieve Milestones in Partnership to Support Trials
19 Sep 2023 //
GLOBENEWSWIRE
Almac Expands Next-Gen Sequencing Capabilities with Illumina NovaSeq X Plus
30 Aug 2023 //
CONTRACT PHARMA
Illumina`s $7.1B Grail deal being investigated by SEC
10 Aug 2023 //
ENDPTS
Illumina slashes outlook for 2023, two executives depart
09 Aug 2023 //
ENDPTS
EU orders Illumina to pay $476M fine over unapproved Grail deal
13 Jul 2023 //
ENDPTS
MedGenome acquires Illumina`s NovaSeq X Plus & Launches Sequencing Test KaryoSeq
11 Jul 2023 //
PR NEWSWIRE
As it searches for a new CEO, Illumina faces a high-stakes year of challenges
29 Jun 2023 //
ENDPTS
Illumina begins layoffs as part of $100M cost-cutting plan
27 Jun 2023 //
FIERCE BIOTECH
Illumina CEO Francis deSouza resigns, following challenge by activist investor
11 Jun 2023 //
ENDPTS
Acrobat, NanoString, and Illumina Accelerator Collaborate with Stanford Medicine
08 Jun 2023 //
BUSINESSWIRE
Illumina names Hologic CEO as new board member and chair
02 Jun 2023 //
ENDPTS
Illumina shareholders oust board chair, CEO survives Carl Icahn proxy battle
25 May 2023 //
CNBC
Illumina chairman ousted from board as activist investor Icahn wins victory
25 May 2023 //
ENPTS
Illumina shareholders vote in one Icahn nominee over chairman
25 May 2023 //
FIERCE BIOTECH
Proxy adviser ISS supports only one of Icahn`s candidates for Illumina board
12 May 2023 //
ENDPTS
Severe Flaws In Illumina DNA Sequencing Technology, CISA Warns
28 Apr 2023 //
INFORMATION SECURITY
FDA warns some Illumina DNA sequencing devices could be vulnerable to hackers
28 Apr 2023 //
ENDPTS
Ravgen settles patent fight with Illumina over genetic testing
17 Apr 2023 //
REUTERS
Illumina, Henry Ford to explore DNA testing for heart disease
17 Apr 2023 //
FIERCE BIOTECH
US FTC orders Illumina to divest cancer detection test maker Grail
03 Apr 2023 //
REUTERS
Icahn, Illumina privately discussed settlement before public fight - filing
30 Mar 2023 //
REUTERS
Illumina and GenoScreen Launch Sequencing Innovation to Eliminate Tuberculosis
24 Mar 2023 //
PR NEWSWIRE
Illumina, Icahn trade jabs over Grail buy as proxy fight looms
20 Mar 2023 //
FIERCE BIOTECH
Illumina and Myriad expand partnership to broaden access to HRD testing
02 Mar 2023 //
GLOBENEWSWIRE
After a bad quarter, Illumina focuses on new DNA sequencing platform
08 Feb 2023 //
ENDPTS
Amgen, Illumina, and Nashville Biosciences Announce Genome Sequencing Agreement
27 Jan 2023 //
PHARMTECH
Illumina Ventures Announces Strategic New Additions to its Investment Team
24 Jan 2023 //
BUSINESSWIRE
